Press Releases
Expert System Grants Researchers Access to AI-Based CRN Tool
Expert System joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based Clinical Research Navigator (CRN) tool effective immediately and extending through at least July 1. CRN contains a structured real-time data set of...
Drug Research
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and...
Press Releases
Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology
Ultragenyx Pharmaceutical Inc , a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, announced a strategic partnership and non-exclusive license and technology access agreement with Daiichi Sankyo Company, Limited for...
Drug Research
Chembio Announces Launch of DPP COVID-19 Serological Point-of-Care Test
Chembio Diagnostics, Inc. , a leading point-of-care diagnostic company focused on infectious diseases, announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test for the detection of IgM and IgG antibodies. These results can be obtained within...
Clinical Trials
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials
PHARMASEAL International, provider of clinical trials management systems has announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and...
Drug Research
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
Eli Lilly and Company announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. The collaboration will study up to four novel preclinical...
Press Releases
Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus
Covalon Technologies Ltd , an advanced medical technologies company, announces its new breakthrough antimicrobial technology formulated to kill the COVID-19 virus (or “SARS-CoV-2”) and other viruses, bacteria, and pathogens.
The new technology, called CovaGuard™, has been specifically formulated to be...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read